World of DTC Marketing

APRIL 12, 2021

A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. Can patients really be confident in pharma supply chains? Why would a pharma company take risks like these?

Generic Drugs 187

Generic Drugs Manufacturing Drugs Production 187

pharmaphorum

OCTOBER 7, 2021

The factory will be able to supply up to 500 million doses of mRNA shots a year, and cover the full spectrum of manufacturing from drug substance production through to full/finish and packaging, according to the company.

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

pharmaphorum

AUGUST 25, 2021

It’s now globally accessible due to Gilead’s work with a network of generic manufacturers and their ability to sign licensing agreements just days after the US FDA registered its authorisation. We went back to what we do best … we engaged our network of companies. It’s not a coincidence that we now have over 2.3

Marketing 52

Marketing Licensing Licensing Manufacturing 52

Advarra

JULY 19, 2022

Q: What is the typical time period between the submission of the briefing package and the pre-IND meeting? A: The FDA’s guidance document indicates the briefing package is submitted four weeks before the meeting. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval.

Packaging 52

Packaging Packaging Drugs Containment 52

Pharma Marketing Network

OCTOBER 27, 2020

So a doctor that’s licensed stay only in the state of New York would be able to practice across the entire counties using Telemedicine.

Insulin 52

Insulin Marketing Doctors Doctor 52

Pharma Marketing Network

OCTOBER 27, 2020

So a doctor that’s licensed stay only in the state of New York would be able to practice across the entire counties using Telemedicine.

Insulin 52

Insulin Doctors Doctor Marketing 52

pharmaphorum

JUNE 11, 2021

The Philadelphia-based company said it had taken the decision to go down the biologics license application (BLA) route for Covaxin based on FDA feedback to the EUA data package it had submitted to the agency. Bharat has also reported data suggesting the shot is effective against the beta (B.1.351) 1.351) variant.

Vaccine 81

Vaccine Vaccination Clinical Trials Clinical Trials 81